Impaired basal sympathetic tone and α1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 11, Issue 2, 1998, Pages 219-229

  Laflamme, Annik K ^a   Wu, Lingyun ^a   Foucart, Sylvain ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Genetic hypertension; Inositol phosphate; Melatonin; Norepinephrine release; Sympathetic activity

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; INOSITOL PHOSPHATE; MELATONIN; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; TRITIUM;

ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART ATRIUM; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE;

ANIMALS; BLOOD PRESSURE; CATECHOLAMINES; HEART RATE; HYPERTENSION; MALE; MELATONIN; NOREPINEPHRINE; PHOSPHATIDYLINOSITOLS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1; REFLEX; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031931576     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00401-9     Document Type: Article

References (28)

1. Zanaboni A, Zanaboni-Muciaccia W: Experimental hypertension in pinealectomized rats. Life Sci 1967;6:2327-2331.
2. Karppanen H, Airaksinen MM, Sarkimaki I: Effects in rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedule. Ann Med Exp Biol Fenn 1973;51:93-103.
3. Kinson GA, Singer B: Effect of pinealectomy on adrenocortical secretion in normal rats and in rats with experimental renal hypertension J Endocrinol 1967;37: xxxvii-xxxviii.
4. Motta M, Schiaffini O, Piva F, et al: Pineal principles and the control of adrenocorticotropin secretion, in Wolstenholme GEW, Knight J (eds): The Pineal Gland. A Ciba Foundation Symposium. Churchill Livingstone, Edinburgh, 1971, pp. 279-291.
5. Holmes SW, Sugden D: The effect of melatonin on phenylephrine-induced hypertension in the rat. Br J Pharmacol 1975;56:360P-361P.
6. Kawashima K, Miwa Y, Fujimoto K, et al: Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens [A], 1987; A9(7): 1121-1131.
7. Birau N, Peterssen U, Meyer C, et al: Hypotensive effect of melatonin in essential hypertension. IRCS Med Sci 1981;9:906.
8. Peuler JD, Johnson GA: Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977;21:625-636.
9. 3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats. Am J Hypertens 1996;9:61-69.
10. Wu L, de Champlain J: Inhibition by cyclic AMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 1996; 14:593-599.
11. Chuang JI, Chen SS, Lin MT: Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacol 1993;47:91-97.
12. Kawashima K, Nagakura A, Wurzburger RJ, et al: Melatonin in serum and the pineal of spontaneously hypertensive rat. Clin Exp Hypertens [A] 1984; A6(8): 1517-1528.
13. Karppanen H, Vapaatalo H, Lahovaara S, et al: Studies with pinealectomized rats. Pharmacol 1970;3:76-84.
14. Karppanen H, Vapaatalo H: Effects of an aldosterone antagonist, spironolactone, on pinealectomized rats. Pharmacol 1971;6:257-264.
15. K-Laflamme A, Oster L, Cardinal R, et al: Effects of renin-angiotensin blockade on sympathetic reactivity and β-adrenergic pathway in SHR. Hypertension 1997; 30(part 1):278-287.
16. Borkowski KR: Effect of adrenal demedullation and adrenaline on hypertension development and vascular reactivity in young spontaneously hypertensive rats. J Autonom Pharmacol 1991;11:1-14.
17. Oster L, Laflamme AK, Foucart S, et al: Losartan improves endothelial functions of mesenteric arteries in three experimental models of hypertension (abst). Hypertension 1995:25:1360.
18. Yasin SA, Grossman A, Forsling ML: Diurnal variation in the effect of melatonin on neurohypophysial hormone release from the rat hypothalamus. Brain Res Bull 1996;39:1-5.
19. Zisapel N, Egozi Y, Laudon M: Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology 1985;40:102-108.
20. Gauer F, Masson-Pevet M, Skene D, et al: Daily rhythm of melatonin binding sites in rat par tuberalis and suprachiasmatic nuclei: evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology 1993;57:120-126.
21. Laitinen JT, Viswanathan M, Vakkuri O, et al: Differential regulation of rat melatonin receptors: selective age-associated decline and lack of melatonin-induced changes. Endocrinology 1992;130:2139-2144.
22. Viswanathan M, Laitinen JT, Saavedra JM: Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology 1992;56:864-870.
23. Krause DN, Barrios VE, Duckles SP: Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 1995;276:207-213.
24. Krause DN, Barrios VE, Doolen S, Duckles SP: Melatonin ML-1 receptors potentiate adrenergic mediated contraction in rat caudal but not femoral or mesenteric arteries (abstract). Can J Physiol Pharmacol 1994; 72(suppl. 1):156.
25. Reiter RJ, Melchiorri D, Sewerynek E, et al: A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
26. Dubocovich ML: Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-56.
27. Menendez-Pelaez A, Reiter RJ: Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15:59-69.
28. Wu L, Wang R, de Champlain J: Enhanced inhibition by melatonin of α-adrenoceptor-induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from SHR. J Hypertens (in press).